MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Essential tremor(ET)"

  • 2018 International Congress

    Therapeutic exposures of CX-8998, a potent, selective and state dependent Cav3 channel antagonist in development for Essential Tremor and Parkinson’s disease Tremor in Cav3 driven neurological models

    M. Lee, E. Newbold, S. Papapetropoulos (Cambridge, MA, USA)

    Objective: In this study, we utilized preclinical data to establish predicted human therapeutic exposures of the potent, selective and state-dependent Cav3 channel antagonist, CX-8998, currently…
  • 2018 International Congress

    Local field potential changes during sleep in the PSA of patients with essential tremor

    L. Mueller, A. Auchter, M. Reich, F. Steigerwald, J. Volkmann (Wuerzburg, Germany)

    Objective: To investigate changes in local field potential (LFP) activity of the posterior subthalamic area (PSA) in patients with essential tremor (ET) during wakefulness and…
  • 2018 International Congress

    Botulinum Toxin Injections in Upper Limb Tremor

    W. Fung, M. Ligtermoet, K. Bertram, D. Williams, J. Kamel (Melbourne, Australia)

    Objective: To prospectively assess the outcome of patients receiving botulinum toxin (BoNT) injections for upper limb tremor refractory to oral medications. Background: Upper limb tremor…
  • 2018 International Congress

    Proof-of-Principle Quantitative EEG Study of CX-8998, an Oral, Potent and Selective T-Type Calcium antagonist in development for symptomatic treatment of Essential Tremor and Parkinson’s disease Tremor

    S. Papapetropoulos, M. Lee, S. Boyer (Cambridge, MA, USA)

    Objective: To study the pharmacodynamics (PD) of CX-8998, using pharmaco-electroencephalography (phEEG) and define plasma concentrations of CX-8998 which are pharmacologically active on objective CNS parameters.…
  • 2018 International Congress

    The utility of electrophysiological tests in the differentiation of upper limb tremor in young-onset patients

    P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To explore the diagnostic utility of neurophysiologic tests in young-onset patients who present primarily with upper limb action tremor. Background: In young-onset patients, isolated…
  • 2018 International Congress

    Magnetic resonance-guided focused ultrasound unilateral thalamotomy for the treatment of essential tremor: Outcomes and complications after 1 year of follow-up in 21 patients

    J. Máñez-Miró, L. Vela, F. Alonso-Frech, M. Di Leone, F. Hernández-Fernández, M. Del Álamo, J. Pineda-Pardo, R. Rodríguez-Rojas, E. de Luis-Pastor, R. Martínez-Fernández (Madrid, Spain)

    Objective: To report the clinical experience in our center (CINAC-HM Puerta del Sur) in the treatment of essential tremor (ET) with Magnetic Resonance guided Focused…
  • 2017 International Congress

    Patients with Essential Tremor Live Longer than their Relatives

    C. Akbostanci, K. Doğanyiğit, M. Şen, E. Onat, A. Tekinay, T. Özçelik, M. Akbostanci (Snoqualmie, WA, USA)

    Objective: The objective of this study is to compare the lifespans of patients with essential tremor (ET) with their relatives. Background: Essential tremor is a movement disorder…
  • 2017 International Congress

    Clinical characteristics of Parkinson’s disease developed from essential tremor

    D.-W. Ryu, J.-S. Kim, K.-S. Lee, J.-W. Park (Seoul, Republic of Korea)

    Objective: The objective of this study is to compare the clinical characteristics of Parkinson’s disease developed from essential tremor (ET-PD) with the clinical characteristics of…
  • 2017 International Congress

    Essential Tremor and Depression

    S. Aslam, N. Zhang, C. Adler, J. Caviness, E. Driver-Dunckley, S. Mehta, M. Sabbagh, T. Beach, H. Shill (Phoenix, AZ, USA)

    Objective: To determine if depression and neuropsychiatric symptoms are more prevalent in patients with essential tremor (ET) compared with non-ET controls and if so, to establish…
  • 2017 International Congress

    Non-motor symptoms in patients with Parkinson’s disease, essential tremor and both diseases – a group comparison

    I. Wurster, A. Abaza, K. Brockmann, M. Rüdiger-Albers, S. Lerche, D. Berg (Tübingen, Germany)

    Objective: To evaluate non-motor symptoms in patients with essential tremor (ET), tremordominant Parkinson’s disease (PD) and those suffering from both diseases (ET-PD). Background: ET is…
  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 45
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley